Bupivacaine vs Bupivacaine and dexmedetomidine for caudal epidural blocks as an adjuvant to general anesthesia in lumbosacral surgeries.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308663873345

Enrollment

Registered

2023-08-07

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases Orthopaedics Anaesthesia

Interventions

Bupivacaine for combined caudal epidural blocks with general anesthesia in lumbosacral surgeries

Bupivacaine and dexmedetomidine for caudal epidural blocks with GA in lumbosacral surgeries.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years. 2. Sex: Both sexes. 3. American Society of Anesthesiologists (ASA) Physical Status Class-I and II. 4. Scheduled for lumbosacral surgery with instrumental fixation under General Anesthesia

Exclusion criteria

Exclusion criteria: 1. Declining to give written informed consent or preoperative neurological defects as sensory or motor dysfunction that hinders informed consent. 2. History of allergy to the medications used in the study. 3. Contraindications to regional anesthesia (including coagulopathy and local infection). 4. Drug abusers either opioids or NSAIDs.

Design outcomes

Primary

Measure	Time frame
Duration of postoperative analgesia.	—

Secondary

Measure	Time frame
One-day postoperative opioid consumption.	—

Countries

Egypt

Contacts

Public ContactMostafa Mansour

Assistant Professor of Anesthesia

mostafa.mansour@med.asu.edu.eg+201093322145

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026